 | • レポートコード：MRC2311A0089 • 出版社/出版日：360iResearch / 2023年10月25日 • レポート形態：英文、PDF、181ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医薬品 |
| Single User（1名利用、印刷不可、1年間閲覧） | ￥584,452 (USD3,949) | ▷ お問い合わせ |
| Site License（同一拠点内共有可、印刷可） | ￥1,028,452 (USD6,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 口腔乾燥症治療薬市場規模は2022年に21.3億ドルと推定され、2023年には22.4億ドルに達し、CAGR 4.65%で2030年には30.7億ドルに達すると予測されています。 市場細分化とカバー範囲： この調査レポートは、口腔乾燥症治療薬市場の包括的な見通しを提供するために、様々なサブ市場を分析し、収益を予測し、各カテゴリの新たな動向を調査しています。 ● 提供に基づいて、市場はOTCと処方箋で調査されます。OTCは予測期間中に大きな市場シェアを占めると予測されています。 ● 薬物タイプ別では、歯磨剤、唾液分泌促進剤、唾液代用剤について調査しています。歯磨剤は予測期間中に大きな市場シェアを占めると予測されています。 ● 流通チャネル別では、市場は病院と薬局で調査されています。薬局はさらにオフラインとオンラインで調査されています。薬局は予測期間中に大きな市場シェアを獲得すると予測されています。 ● 地域別では、米州、アジア太平洋地域、欧州・中東・アフリカ地域で調査しています。米州はさらにアルゼンチン、ブラジル、カナダ、メキシコ、米国で調査されています。米国はさらにカリフォルニア、フロリダ、イリノイ、ニューヨーク、オハイオ、ペンシルバニア、テキサスで調査されています。アジア太平洋地域は、オーストラリア、中国、インド、インドネシア、日本、マレーシア、フィリピン、シンガポール、韓国、台湾、タイ、ベトナムで調査されています。ヨーロッパ・中東・アフリカは、デンマーク、エジプト、フィンランド、フランス、ドイツ、イスラエル、イタリア、オランダ、ナイジェリア、ノルウェー、ポーランド、カタール、ロシア、サウジアラビア、南アフリカ、スペイン、スウェーデン、スイス、トルコ、アラブ首長国連邦、イギリスを対象としている。南北アメリカは予測期間中に大きな市場シェアを占めると予測されています。 市場統計： 本レポートでは、7つの主要通貨（ドル、ユーロ、日本円、英ポンド、豪ドル、カナダドル、スイスフラン）の市場規模と予測を掲載しています。本レポートでは、2018年から2021年までを過去年、2022年を基準年、2023年を推定年、2024年から2030年までを予測期間としています。 FPNVポジショニングマトリックス： FPNVポジショニングマトリックスは口腔乾燥症治療薬市場を評価するのに不可欠なツールです。事業戦略と製品満足度に関連する主要指標を分析し、企業を包括的に評価します。これにより、ユーザーは特定のニーズに合わせた情報に基づいた意思決定を行うことができます。高度な分析により、企業は4つの象限に分類され、それぞれ成功のレベルが異なります： フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。この洞察に満ちたフレームワークにより、意思決定者は自信を持って市場をナビゲートすることができます。 市場シェア分析： 市場シェア分析は、口腔乾燥症治療薬市場の企業情報に関する貴重な洞察を掲載しています。全体的な収益、顧客基盤、その他の主要指標に対する影響を評価することで、各社の業績と直面している競争環境について包括的な理解を掲載しています。この分析では、調査期間中の市場シェア獲得、断片化、優位性、業界再編などの競争レベルも明らかにします。 主要企業のプロフィール： 本レポートでは、口腔乾燥症治療薬市場における最近の重要な動向を掘り下げ、主要企業とその革新的なプロフィールを紹介しています。これらには、3M Company、Advanz Pharma Corp.、Bausch Health Companies Inc.、Bio Cosmetics Laboratories, S.L.、Biodexa Pharmaceuticals PLC、CCMed Ltd.、Chattem, Inc. by Sanofi S.A.、Cipla Ltd.、Colgate-Palmolive Company、Cyclacel Pharmaceuticals, Inc.、Forward Science、Fresenius Kabi AG、Fresenius SE & Co. KGaA、GlaxoSmithKline PLC、Hikma Pharmaceuticals PLC、ICPA Health Products Ltd、Lupin Limited、Mission Pharmacal Company、Parnell Pharmaceuticals Inc.、Perrigo Company plc、Pharmascience Inc.、Quest Products Inc.、Saliwell Ltd.、Sun Pharmaceutical Industries Ltd.、Synedgen Inc.などの企業が含まれています。 本レポートは、以下の側面に関する貴重な洞察を掲載しています： 1. 市場浸透： 主要企業の市場ダイナミクスと製品に関する包括的な情報を掲載しています。 2. 市場開拓： 新興市場と成熟市場セグメントへの浸透を詳細に分析し、有利な機会を強調します。 3. 市場の多様化： 新製品の発売、未開拓の地域、最近の開発、投資に関する詳細情報。 4. 競合他社の評価とインテリジェンス： 主要企業の市場シェア、戦略、製品、認証、規制当局の承認、特許状況、製造能力を網羅的に評価。 5. 製品開発とイノベーション： 将来の技術、研究開発活動、画期的な製品開発に関する知的洞察。 本レポートは、以下のような主要な質問に対応しています： 1. 口腔乾燥症治療薬市場の市場規模および予測は？ 2. 口腔乾燥症治療薬市場で最も高い投資ポテンシャルを持つ製品、セグメント、用途、分野はどれか？ 3. 口腔乾燥症治療薬市場の機会を特定するための競争戦略窓口は？ 4. 口腔乾燥症治療薬市場の最新技術動向と規制枠組みは？ 5. 口腔乾燥症治療薬市場における主要企業の市場シェアは？ 6. 口腔乾燥症治療薬市場への参入に適したモードと戦略的動きは？ |
1. 序論
2. 調査方法
3. エグゼクティブサマリー
4. 市場概要
5. 市場インサイト
6. 口腔乾燥症治療薬の世界市場：製品別
7. 口腔乾燥症治療薬の世界市場：薬剤タイプ別
8. 口腔乾燥症治療薬の世界市場：流通チャネル別
9. アメリカの口腔乾燥症治療薬市場
10. アジア太平洋の口腔乾燥症治療薬市場
11. ヨーロッパ、中東/アフリカの口腔乾燥症治療薬市場
12. 競争状況
13. 競合ポートフォリオ
14. 付録
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Xerostomia Therapeutics Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidences of xerostomia in the aging population
5.1.1.2. Growing awareness about xerostomia-related products
5.1.1.3. Ongoing research and development for the development of efficient products for xerostomia
5.1.2. Restraints
5.1.2.1. High cost of medications and medical treatments associated with xerostomia therapies
5.1.3. Opportunities
5.1.3.1. Improvements in xerostomia drugs and treatments
5.1.3.2. Clinical trials to study the efficacy of xerostomia drugs
5.1.4. Challenges
5.1.4.1. Strict regulations pertaining to marketing and selling xerostomia-related products
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
6. Xerostomia Therapeutics Market, by Offering
6.1. Introduction
6.2. OTC
6.3. Prescription
7. Xerostomia Therapeutics Market, by Drug Type
7.1. Introduction
7.2. Dentifrices
7.3. Salivary Stimulants
7.4. Salivary Substitutes
8. Xerostomia Therapeutics Market, by Distribution Channel
8.1. Introduction
8.2. Hospital
8.3. Pharmacies
8.4.1. Offline
8.4.2. Online
9. Americas Xerostomia Therapeutics Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Xerostomia Therapeutics Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Xerostomia Therapeutics Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. 3M Company
13.1.2. Advanz Pharma Corp.
13.1.3. Bausch Health Companies Inc.
13.1.4. Bio Cosmetics Laboratories, S.L.
13.1.5. Biodexa Pharmaceuticals PLC
13.1.6. CCMed Ltd.
13.1.7. Chattem, Inc. by Sanofi S.A.
13.1.8. Cipla Ltd.
13.1.9. Colgate-Palmolive Company
13.1.10. Cyclacel Pharmaceuticals, Inc.
13.1.11. Forward Science
13.1.12. Fresenius Kabi AG
13.1.13. Fresenius SE & Co. KGaA
13.1.14. GlaxoSmithKline PLC
13.1.15. Hikma Pharmaceuticals PLC
13.1.16. ICPA Health Products Ltd
13.1.17. Lupin Limited
13.1.18. Mission Pharmacal Company
13.1.19. Parnell Pharmaceuticals Inc.
13.1.20. Perrigo Company plc
13.1.21. Pharmascience Inc.
13.1.22. Quest Products Inc.
13.1.23. Saliwell Ltd
13.1.24. Sun Pharmaceutical Industries Ltd.
13.1.25. Synedgen Inc.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2022
TABLE 3. XEROSTOMIA THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 6. XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OTC, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PRESCRIPTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 9. XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DENTIFRICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. XEROSTOMIA THERAPEUTICS MARKET SIZE, BY SALIVARY STIMULANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. XEROSTOMIA THERAPEUTICS MARKET SIZE, BY SALIVARY SUBSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 13. XEROSTOMIA THERAPEUTICS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 16. XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. XEROSTOMIA THERAPEUTICS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS XEROSTOMIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 31. CANADA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 32. CANADA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 33. CANADA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 34. CANADA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 35. MEXICO XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 36. MEXICO XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 37. MEXICO XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 38. MEXICO XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 44. ASIA-PACIFIC XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 45. ASIA-PACIFIC XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 46. ASIA-PACIFIC XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC XEROSTOMIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 49. AUSTRALIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 50. AUSTRALIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 51. AUSTRALIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 52. AUSTRALIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 53. CHINA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 54. CHINA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 55. CHINA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 56. CHINA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 57. INDIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 58. INDIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 59. INDIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 60. INDIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 61. INDONESIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 62. INDONESIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 63. INDONESIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 64. INDONESIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 65. JAPAN XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 66. JAPAN XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 67. JAPAN XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 68. JAPAN XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 69. MALAYSIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 70. MALAYSIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 71. MALAYSIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. MALAYSIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 73. PHILIPPINES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 74. PHILIPPINES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 75. PHILIPPINES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 76. PHILIPPINES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 77. SINGAPORE XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 78. SINGAPORE XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 79. SINGAPORE XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 80. SINGAPORE XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 81. SOUTH KOREA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 82. SOUTH KOREA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 83. SOUTH KOREA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 84. SOUTH KOREA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 85. TAIWAN XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 86. TAIWAN XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 87. TAIWAN XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 88. TAIWAN XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 89. THAILAND XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 90. THAILAND XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 91. THAILAND XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 92. THAILAND XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 93. VIETNAM XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 94. VIETNAM XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 95. VIETNAM XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 96. VIETNAM XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 102. DENMARK XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 103. DENMARK XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 104. DENMARK XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 105. DENMARK XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 106. EGYPT XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 107. EGYPT XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 108. EGYPT XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 109. EGYPT XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 110. FINLAND XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 111. FINLAND XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 112. FINLAND XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 113. FINLAND XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 114. FRANCE XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 115. FRANCE XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 116. FRANCE XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. FRANCE XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 118. GERMANY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 119. GERMANY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 120. GERMANY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 121. GERMANY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 122. ISRAEL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 123. ISRAEL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 124. ISRAEL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 125. ISRAEL XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 126. ITALY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 127. ITALY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 128. ITALY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. ITALY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 130. NETHERLANDS XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 131. NETHERLANDS XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 132. NETHERLANDS XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 133. NETHERLANDS XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 134. NIGERIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 135. NIGERIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 136. NIGERIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 138. NORWAY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 139. NORWAY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 140. NORWAY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 141. NORWAY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 142. POLAND XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 143. POLAND XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 144. POLAND XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. POLAND XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 146. QATAR XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 147. QATAR XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 148. QATAR XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 149. QATAR XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 150. RUSSIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 151. RUSSIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 154. SAUDI ARABIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 158. SOUTH AFRICA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 159. SOUTH AFRICA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 162. SPAIN XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 163. SPAIN XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 164. SPAIN XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 165. SPAIN XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 166. SWEDEN XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 167. SWEDEN XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 168. SWEDEN XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 169. SWEDEN XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 170. SWITZERLAND XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 171. SWITZERLAND XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 172. SWITZERLAND XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 173. SWITZERLAND XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 174. TURKEY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 175. TURKEY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 176. TURKEY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 177. TURKEY XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 178. UNITED ARAB EMIRATES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 182. UNITED KINGDOM XEROSTOMIA THERAPEUTICS MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM XEROSTOMIA THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM XEROSTOMIA THERAPEUTICS MARKET SIZE, BY PHARMACIES, 2018-2030 (USD MILLION)
TABLE 186. XEROSTOMIA THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 187. XEROSTOMIA THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2022
TABLE 188. XEROSTOMIA THERAPEUTICS MARKET LICENSE & PRICING